Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON28948
NL-OMON28948
Not yet recruiting
Not Applicable

[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.

VU University Medical Center0 sites10 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionson-small cell lung cancer NSCLCNiet-kleincellig longkanker

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
VU University Medical Center
Enrollment
10
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients with NSCLC, planned to receive erlotinib for therapy will be included in this study. Ten evaluable patients are needed. It is expected that this number of patients will be recruited within 1 year.
  • •1\. Patients age: Between 18 and 70 years;

Exclusion Criteria

  • •1\. Claustrophobia;
  • •2\. Pregnant or lactating patients;

Investigators

Sponsor
VU University Medical Center

Similar Trials

Completed
Not Applicable
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.lung cancernon-small cell lung carcinoma10038666
NL-OMON36826Vrije Universiteit Medisch Centrum10
Completed
Not Applicable
Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancerAdvanced non-small cell lung cancer
JPRN-UMIN000012862Shizuoka cancer center70
Completed
Not Applicable
[11C]Erlotinib tumor heterogeneity: an in vivo study using static whole body positron emission tomography in non-small cell lung cancer patients.
NL-OMON44987Vrije Universiteit Medisch Centrum30
Recruiting
Not Applicable
Imaging of [11C]erlotinib pharmacokinetics in non small cell lung cancer patients; an in vivo study with positron emission tomographylung cancer10038666
NL-OMON32923Vrije Universiteit Medisch Centrum10
Active, not recruiting
Not Applicable
Pharmacodynamic study of Erlotinib (Tarceva) in patients with mestastatic or locally advanced Epidermoid carcinoma of the head and neckMestastatic or locally advanced Epidermoid carcinoma of the head and neck
EUCTR2005-003814-14-ESnidad Integral de Investigación en Oncología, S.L.49